News

According to research, an experimental drug could prevent or slow vision loss in people with diabetes.

Gas-Releasing Adjuvant Improves Efficacy of Photothermal Therapy for Cancer

Five subtypes of heart failure that could potentially be used to predict future risk for individual patients have been identified in a new study.

Researchers have identified a novel signaling molecule that could lead to the development of novel therapeutics for the prevention and treatment of obesity and diabetes.

An research team have been developing a personalized mRNA cancer-treatment vaccine approach. It is designed to help immune cells recognize specific neoantigens on patients’ pancreatic cancer cells.

Hello and welcome to the Pulse, the monthly psychedelics industry roundup from Technology Networks and Analytical Cannabis. Here, we’ll highlight some of the most significant psychedelic industry news from the past month, including important announcements, pre-clinical work and the latest from groundbreaking psychedelic clinical trials.

Mount Sinai researchers have published what they say is the first study to identify a new form of treatment for rapid eye movement (REM) sleep behavior disorder.

Researchers have recently revealed that the gene Chinmo is resoposible for establishing the juvenile stage in insects, and may play a key role in metamorphosis.

Data from a Mount Sinai-led phase 3 trial published today in The New England Journal of Medicine show that upadacitinib, a breakthrough, once-daily oral medication, helps patients achieve and maintain clinical and endoscopic remission.

Word choice matters—a lot— when it comes to research. That's the conclusion of a new study that analyzed HIV-related stigmatizing language published in scientific literature from 2010 to 2020.